3-D Matrix, Ltd. (DMTRF)
OTC Markets OTCPK · USD · Healthcare · Medical Devices
$2.43 (+0.00%) as of
Key statistics
- Market cap
- 310.35M
- P/E (TTM)
- 14.26
- EPS (TTM)
- 0.1700
- Dividend yield
- 0.00%
- 52-week range
- 1.5000 – 3.9600
- Beta
- 0.99
- Revenue (TTM)
- 11.92B
- Profit margin
- 30.98%
- Volume
- 1.50k
About 3-D Matrix, Ltd.
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Tokyo, Japan
- Employees
- 129
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.